Local Control in Pelvic Ewing Sarcoma: Analysis From INT-0091—A Report From the Children's Oncology Group
Torunn I. Yock(Massachusetts General Hospital), Nancy J. Tarbell(Harvard University), Sarah S. Donaldson(Stanford University), James S Miser(City of Hope), Fran Laurie(University of Massachusetts Chan Medical School), Mark L. Bernstein(University of Louisville), Mark C. Gebhardt(Boston Children's Hospital), Mark Krailo(Arcadia), Christopher Fryer(BC Children's Hospital), Zhengjia Chen(Hunan University of Traditional Chinese Medicine), Holcombe E. Grier(Harvard University)
Cited by 156
Related Papers
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
|Proceedings of the National Academy of Sciences|2017|899
The “Gender Gap” in Authorship of Academic Medical Literature — A 35-Year Perspective
|New England Journal of Medicine|2006|873
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
|The Lancet Oncology|2016|537
Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study
|JNCI Journal of the National Cancer Institute|2009|530